sábado, 3 de febrero de 2024

Children’s National gives first commercial dose of new FDA-approved gene therapy for Duchenne muscular dystrophy

https://innovationdistrict.childrensnational.org/childrens-national-gives-first-dose-of-new-dmd-drug/

No hay comentarios:

Publicar un comentario